Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cutaneous Manifestations of Chronic Liver Disease.
Patel AD, Katz K, Gordon KB. Patel AD, et al. Among authors: gordon kb. Clin Liver Dis. 2020 Aug;24(3):351-360. doi: 10.1016/j.cld.2020.04.003. Epub 2020 May 29. Clin Liver Dis. 2020. PMID: 32620276 Review.
Anti-IL 23 biologics for the treatment of plaque psoriasis.
Vu A, Ulschmid C, Gordon KB. Vu A, et al. Among authors: gordon kb. Expert Opin Biol Ther. 2022 Dec;22(12):1489-1502. doi: 10.1080/14712598.2022.2132143. Epub 2022 Oct 27. Expert Opin Biol Ther. 2022. PMID: 36243011 Review.
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial.
Morita A, Strober B, Burden AD, Choon SE, Anadkat MJ, Marrakchi S, Tsai TF, Gordon KB, Thaçi D, Zheng M, Hu N, Haeufel T, Thoma C, Lebwohl MG. Morita A, et al. Among authors: gordon kb. Lancet. 2023 Oct 28;402(10412):1541-1551. doi: 10.1016/S0140-6736(23)01378-8. Epub 2023 Sep 19. Lancet. 2023. PMID: 37738999 Clinical Trial.
Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation Analysis.
Armstrong AW, Foley P, Liu Y, Miller M, Teneralli RE, Bewley A, Gordon KB, Papp KA, Han C. Armstrong AW, et al. Among authors: gordon kb. Dermatol Ther (Heidelb). 2024 Sep;14(9):2577-2589. doi: 10.1007/s13555-024-01250-9. Epub 2024 Aug 23. Dermatol Ther (Heidelb). 2024. PMID: 39177870 Free PMC article.
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials.
Armstrong AW, Augustin M, Beaumont JL, Pham TP, Hudgens S, Gordon KB, Zhuo J, Becker B, Zhong Y, Kisa RM, Banerjee S, Papp KA. Armstrong AW, et al. Among authors: gordon kb. Dermatol Ther (Heidelb). 2024 Aug;14(8):2235-2248. doi: 10.1007/s13555-024-01224-x. Epub 2024 Jul 30. Dermatol Ther (Heidelb). 2024. PMID: 39080153 Free PMC article.
182 results